PTCT PTC Therapeutics, Inc. - Common Stock
PTC Therapeutics, Inc. - Common Stock के बारे में विकिपीडिया से कंपनी का अवलोकन
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
और पढ़ें
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
In September 2009, PTC entered into an agreement with Roche for the development of orally bioavailable small molecules for central nervous system diseases. PTC acquired the Bio-e platform in 2019.
Products
In 2017, PTC acquired Emflaza (deflazacort) from Marathon Pharmaceuticals. PTC also owns Translarna, (Ataluren) marketed for nonsense mutation Duchenne muscular dystrophy. Together, the two products generated revenues of 174 million dollars and 260 million dollars in 2017 and 2018 respectively.
PTC has the commercialization rights for WAYLIVRA (volanesorsen) in Latin America.
In 2018, PTC acquired Agilis Biotherapeutics and a gene therapy candidate, GT-AADC, with its compelling clinical data in treating aromatic L-amino acid decarboxylase (AADC) deficiency. AADC deficiency is a rare CNS disorder arising from reductions in the enzyme AADC that result from mutations in the dopa decarboxylase (DDC) gene. As of 2024, the AAV based treatment for AADC deficiency has been approved by the FDA and commercialized in the United States as Kebilidi. It is the first FDA-approved gene therapy treatment for AADC deficiency. This same product was granted EMA approval for use in the European Union under the name Upstaza.
Pipeline
In 2020, PTC acquired Censa Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of CNSA-001 (sepiapterin), a clinical-stage investigational therapy for orphan metabolic diseases, including phenylketonuria (PKU) and other diseases associated with defects in the tetrahydrobiopterin (BH4) biochemical pathways diagnosed at birth.
In 2020, PTC announced the FDA approval of Evrysdi (risdiplam) for the treatment of spinal muscular atrophy (SMA) in adults and children 2 months and older.
In 2024, Novartis has committed $1 billion upfront in a licensing deal with PTC Therapeutics for an experimental treatment for Huntington’s disease, with the potential for an additional $1.9 billion tied to achieving specific development, regulatory, and commercial milestones. PTC Therapeutics’ therapy, known as PTC518, is an oral medication designed to reduce the production of the mutant protein linked to the genetic mutation responsible for the disease. This mutant protein is believed to contribute to neuronal death, driving disease progression. In June, interim data from a Phase 2 trial indicated that PTC518 successfully lowered levels of the mutant protein in both blood and cerebrospinal fluid.
स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗
PTCT स्टॉक स्नैपशॉट मूल्य, बाजार पूंजीकरण, P/E, EPS, ROE, ऋण/इक्विटी, 52-सप्ताह की सीमा
PTCT स्टॉक मूल्य चार्ट तकनीकी संकेतकों के साथ दैनिक OHLCV — पैन, ज़ूम और अपना दृश्य कस्टमाइज़ करें
10-वर्षीय प्रदर्शन राजस्व, शुद्ध आय, मार्जिन और ईपीएस रुझान
मूल्यांकन P/E, P/S, P/B, EV/EBITDA अनुपात — क्या स्टॉक महंगा है या सस्ता?
लाभप्रदता सकल, परिचालन और शुद्ध मार्जिन; ROE, ROA, ROIC
वित्तीय स्वास्थ्य ऋण, तरलता, शोधन क्षमता — बैलेंस शीट की मजबूती
विकास राजस्व, EPS और शुद्ध आय वृद्धि: YoY, 3Y CAGR, 5Y CAGR
पूंजी दक्षता एसेट टर्नओवर, इन्वेंटरी टर्नओवर, प्राप्य टर्नओवर
PTCT विश्लेषक सर्वसम्मति तेजी और मंदी के विश्लेषक राय, 12-महीने का मूल्य लक्ष्य, अपसाइड
- मजबूत खरीद 6 28.6%
- खरीदें 11 52.4%
- होल्ड 3 14.3%
- बेचें 1 4.8%
- मजबूत बिक्री 0 0.0%
12-महीने का मूल्य लक्ष्य
14 विश्लेषक · 2026-08-13Earnings History EPS वास्तविक बनाम अनुमान, आश्चर्य %, बीट दर, अगली आय तिथि
| Period | EPS Actual | EPS अनुमान | आश्चर्य |
|---|---|---|---|
| 30 जून 2026 | $0.92 | $0.43 | 0.49% |
| 31 मार्च 2026 | $-0.03 | $-0.48 | 0.45% |
| 31 दिसमबर 2025 | $-1.67 | $0.04 | -1.7% |
| 30 सितमबर 2025 | $0.20 | $-1.40 | 1.6% |
| 30 जून 2025 | $-0.83 | $-1.08 | 0.25% |
| 31 मार्च 2025 | $10.04 | $-0.22 | 10.3% |
सहकर्मी तुलना (GICS उप-उद्योग) प्रमुख मेट्रिक्स बनाम सेक्टर के साथी
| टिकर | मार्केट कैप | P/E | राजस्व YoY | शुद्ध मार्जिन | ROE | सकल मार्जिन |
|---|---|---|---|---|---|---|
| PTCT | $6.19B | 9.8 | 114.5% | 39.4% | -331.5% | — |
| MIRM | $4.10B | -168.1 | 54.7% | -4.5% | -8.2% | — |
| COGT | $5.72B | -16.4 | — | — | -83.1% | — |
| DNTH | $1.78B | -9.8 | -67.3% | -7973.3% | -40.8% | — |
| ERAS | $1.06B | -8.5 | — | — | -35.7% | — |
| CAI | $7.62B | -8.4 | 97.0% | -8.4% | -13.2% | — |
| TVTX | $3.47B | -131.8 | 110.5% | -5.2% | -34.6% | — |
| ACAD | $4.55B | 11.6 | 11.9% | 36.5% | 38.1% | — |
| DYN | $3.23B | -5.6 | — | — | -57.8% | — |
| PBLS | — | — | — | — | — | — |
| CELC | $4.81B | -26.3 | — | — | -244.3% | — |
पूर्ण मौलिक सभी मेट्रिक्स प्रति वर्ष — आय विवरण, बैलेंस शीट, नकदी प्रवाह
आय विवरण 15
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.73B | $807M | $938M | $699M | $539M | $381M | $307M | $265M | $194M | $83M | $37M | $25M | |
| Cost of Revenue | · | · | · | · | · | · | $12M | $13M | $5M | $0 | $0 | · | |
| R&D Expense | $455M | $534M | $667M | $651M | $541M | $478M | $257M | $172M | $117M | $118M | $122M | $80M | |
| SG&A Expense | $347M | $301M | $333M | $326M | $286M | $245M | $203M | $154M | $121M | $97M | $82M | $45M | |
| Operating Expenses | $864M | $1.11B | $1.38B | $1.15B | $913M | $813M | $548M | $380M | $259M | $215M | $204M | $125M | |
| Operating Income | $867M | $-303M | $-440M | $-447M | $-374M | $-432M | $-241M | $-116M | $-64M | $-132M | $-167M | $-99M | |
| Other Non-op | $-18M | $7M | $10M | $-49M | $-58M | $85M | $14M | $129.0K | $-1M | $-1M | $-465.0K | $-213.0K | |
| Pretax Income | $697M | $-363M | $-696M | $-587M | $-518M | $-403M | $-240M | $-128M | $-78M | $-142M | $-170M | $-98M | |
| Income Tax | $14M | $176.0K | $-70M | $-28M | $6M | $35M | $12M | $-29.0K | $1M | $569.0K | $485.0K | $-5M | |
| Net Income | $683M | $-363M | $-627M | $-559M | $-524M | $-438M | $-252M | $-128M | $-79M | $-142M | $-170M | $-94M | |
| EPS (Basic) | $8.58 | $-4.73 | $-8.37 | $-7.79 | $-7.43 | $-6.64 | $-4.27 | $-2.75 | $-2.02 | · | · | $-2.97 | |
| EPS (Diluted) | $7.78 | $-4.73 | $-8.37 | $-7.79 | $-7.43 | $-6.64 | $-4.27 | · | · | · | · | $-2.97 | |
| Shares (Basic) | 79,534,290 | 76,845,055 | 74,838,292 | 71,728,634 | 70,466,393 | 66,027,908 | 58,863,185 | · | · | · | · | 31,565,310 | |
| Shares (Diluted) | 88,311,494 | 76,845,055 | 74,838,292 | 71,728,634 | 70,466,393 | 66,027,908 | 58,863,185 | · | · | · | · | 31,565,310 | |
| EBITDA | $906M | $-227M | $-203M | · | $-310M | $-388M | $-209M | $-90M | $-47M | $-132M | $-167M | $-99M |
बैलेंस शीट 27
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $985M | $780M | $594M | $280M | $190M | $209M | $288M | $169M | $112M | $58M | $58M | $50M | |
| Short-term Investments | $961M | $360M | $283M | $131M | $584M | $895M | $399M | $58M | $79M | $173M | $281M | $265M | |
| Receivables | $182M | $159M | $161M | $156M | $110M | $70M | $56M | $68M | $40M | $25M | $11M | $4M | |
| Inventory | $80M | $23M | $31M | $22M | $16M | $19M | $19M | $16M | $11M | $0 | · | · | |
| Prepaid Expense | $67M | $44M | $150M | $106M | $55M | $39M | $18M | $9M | $7M | $5M | $6M | $4M | |
| Current Assets | $2.27B | $1.37B | $1.22B | $694M | $954M | $1.23B | $779M | $321M | $249M | $261M | $356M | $324M | |
| PP&E (Net) | $55M | $61M | $87M | $73M | $53M | $34M | $22M | $13M | $8M | $7M | $9M | $9M | |
| PP&E (Gross) | $102M | $94M | $138M | $110M | $80M | $52M | $33M | $20M | $41M | $38M | $37M | $34M | |
| Accum. Depreciation | $47M | $33M | $51M | $37M | $27M | $18M | $12M | $7M | $33M | $31M | $28M | $25M | |
| Goodwill | $82M | $82M | $82M | $82M | $82M | $82M | $82M | $82M | $0 | · | · | · | |
| Intangibles | $389M | $119M | $379M | $706M | $725M | $715M | $710M | $701M | $133M | $0 | · | · | |
| Total Assets | $2.90B | $1.71B | $1.90B | $1.71B | $1.94B | $2.21B | $1.62B | $1.12B | $392M | $269M | $365M | $333M | |
| Accounts Payable | $45M | $17M | $6M | $27M | $23M | $19M | $10M | $6M | $15M | $6M | $6M | $4M | |
| Current Liabilities | $968M | $581M | $603M | $406M | $509M | $277M | $236M | $167M | $82M | $50M | $45M | $32M | |
| Capital Leases | $94M | $75M | $98M | $101M | $74M | $79M | $9M | · | · | · | · | · | |
| Deferred Tax | · | · | $56M | $103M | $137M | $137M | $131M | $122M | $0 | · | · | · | |
| Other Non-current Liabilities | $14M | $21M | $141.0K | $3M | · | $1M | $141.0K | $58.0K | $243.0K | $335.0K | $2M | $2M | |
| Total Liabilities | $3.10B | $2.80B | $2.71B | $2.05B | $1.94B | $1.73B | $1.03B | $768M | $235M | $150M | $139M | $35M | |
| Long-term Debt | · | · | · | · | $431M | · | $314M | $153M | $145M | · | · | · | |
| Total Debt | $287M | $285M | $284M | · | $431M | $309M | $314M | $153M | $145M | $98M | $95M | · | |
| Common Stock | $80.0K | $77.0K | $75.0K | $72.0K | $71.0K | $70.0K | $62.0K | $51.0K | $42.0K | $34.0K | $34.0K | $33.0K | |
| Paid-in Capital | $2.75B | $2.57B | $2.47B | $2.31B | $2.12B | $2.17B | $1.80B | $1.29B | $967M | $856M | $820M | $722M | |
| Retained Earnings | $-2.96B | $-3.65B | $-3.28B | $-2.66B | $-2.10B | $-1.63B | $-1.19B | $-939M | $-814M | $-735M | $-593M | $-423M | |
| AOCI | $11M | $-26M | $-1M | $5M | $-24M | $-61M | $-11M | $1M | $4M | $-1M | $-1M | $-737.0K | |
| Stockholders' Equity | $-205M | $-1.10B | $-819M | $-347M | $1M | $482M | $594M | $351M | $156M | $120M | $226M | $298M | |
| Liabilities + Equity | $2.90B | $1.71B | $1.90B | $1.71B | $1.94B | $2.21B | $1.62B | $1.12B | $392M | $269M | $365M | $333M | |
| Shares Outstanding | 81,474,366 | 77,704,188 | 75,708,889 | 73,104,692 | 70,828,226 | 69,718,096 | 61,935,870 | 50,606,147 | 41,612,395 | 34,169,410 | 33,916,559 | 32,898,392 |
नकदी प्रवाह 16
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $39M | $76M | $237M | $129M | $64M | $43M | $32M | $26M | $18M | $3M | $3M | · | |
| Stock-based Comp | $75M | $75M | $102M | $110M | $104M | $70M | $42M | $33M | $31M | $35M | $34M | $19M | |
| Deferred Tax | $-3.0K | $-56M | $-47M | $-34M | $377.0K | $6M | $9M | $0 | $199.0K | $-199.0K | $0 | $0 | |
| Amort. of Intangibles | $25M | $61M | $223M | $117M | $55M | $37M | $28M | $23M | $15M | $0 | $0 | · | |
| Restructuring | · | · | · | · | · | · | · | · | $0 | · | · | · | |
| Other Non-cash | $-85M | $161M | $177M | · | $105M | $124M | $70M | $41M | $20M | · | · | · | |
| Operating Cash Flow | $711M | $-108M | $-158M | $-357M | $-251M | $-194M | $-99M | $-28M | $-10M | $-104M | $-124M | $-57M | |
| CapEx | $9M | $7M | $28M | $32M | $28M | $18M | $14M | $7M | $3M | $2M | $3M | $5M | |
| Investing Cash Flow | $-862M | $44M | $-177M | $290M | $219M | $-562M | $-387M | $-43M | $13M | $104M | $-21M | $-145M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $0 | · | $-49.0K | |
| Stock Issued | · | · | · | · | · | $28M | $324M | $118M | $0 | $0 | $0 | $236M | |
| Net Stock Activity | · | · | · | · | · | $28M | $324M | $118M | · | $0 | · | $236M | |
| Financing Cash Flow | $331M | $256M | $646M | $168M | $21M | $669M | $613M | $132M | $44M | $968.0K | $154M | $237M | |
| Net Change in Cash | $203M | $185M | $314M | $99M | $-19M | $-79M | $126M | $58M | $53M | $299.0K | $8M | $34M | |
| Taxes Paid | $37M | $18M | $14M | $5M | $8M | $26M | $2M | $2M | $1M | $943.0K | $111.0K | $0 | |
| Free Cash Flow | $702M | $-114M | $-187M | · | $-280M | $-212M | $-112M | $-35M | $-13M | $-105M | $-127M | $-62M |
लाभप्रदता 7
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 50.1% | -37.5% | -46.9% | · | -69.5% | -113.4% | -78.6% | -43.7% | -33.1% | -159.7% | -454.6% | -393.8% | |
| Net Margin | 39.4% | -45.0% | -66.8% | · | -97.3% | -115.1% | -82.0% | -48.4% | -40.6% | -171.8% | -463.6% | -371.4% | |
| Pretax Margin | 40.2% | -45.0% | -74.2% | · | -96.2% | -105.8% | -78.2% | -48.4% | -40.0% | -171.1% | -462.3% | -390.0% | |
| EBITDA Margin | 52.3% | -28.1% | -21.6% | · | -57.6% | -102.0% | -68.1% | -33.8% | -24.0% | -159.7% | -454.6% | -393.8% | |
| ROA | 29.7% | -20.2% | -34.8% | · | -25.3% | -22.9% | -18.3% | -17.0% | -23.9% | -44.8% | -48.6% | -38.6% | |
| ROE | -331.5% | 33.8% | 84.1% | · | -985.1% | -88.3% | -40.0% | -34.8% | -57.2% | -82.2% | -65.0% | -43.1% | |
| ROIC | 1044.7% | 37.2% | 74.0% | · | -87.4% | -59.4% | -27.8% | -23.0% | -21.7% | -60.9% | -52.3% | -31.7% |
तरलता और शोधन क्षमता 4
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.3 | 2.4 | 2.0 | · | 1.9 | 4.4 | 3.3 | 1.9 | 3.0 | 5.3 | 7.8 | 10.0 | |
| Quick Ratio | 2.2 | 2.2 | 1.7 | · | 1.7 | 4.2 | 3.1 | 1.8 | 2.8 | 5.2 | 7.7 | 9.8 | |
| Debt / Equity | -1.4 | -0.3 | -0.3 | · | 300.0 | 0.6 | 0.5 | 0.4 | 0.9 | 0.8 | 0.4 | · | |
| LT Debt / Equity | · | -0.3 | -0.3 | · | 196.0 | 0.6 | 0.5 | 0.4 | 0.9 | 0.8 | 0.4 | · |
दक्षता 3
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.4 | 0.5 | · | 0.3 | 0.2 | 0.2 | 0.4 | 0.6 | 0.3 | 0.1 | 0.1 | |
| Inventory Turnover | · | · | · | · | · | · | 0.7 | · | 0.9 | · | · | · | |
| Receivables Turnover | 10.2 | 5.1 | 5.9 | · | 6.0 | 6.1 | 5.0 | 4.9 | 6.0 | 4.6 | 4.7 | 9.3 |
विकास दरें 3
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 114.5% | -14.0% | 34.2% | 29.8% | 41.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 35.3% | 14.4% | 35.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 35.4% | · | · | · | · | · | · | · | · | · | · | · |
मूल्यांकन (TTM) 13
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.73B | $807M | $938M | $699M | $539M | $381M | $307M | $265M | $194M | $83M | $37M | $25M | |
| Net Income TTM | $683M | $-363M | $-627M | $-559M | $-524M | $-438M | $-252M | $-128M | $-79M | $-142M | $-170M | $-94M | |
| Market Cap | $6.19B | $3.51B | $2.09B | · | $2.82B | $4.25B | $2.97B | $1.74B | $694M | $373M | $1.10B | $1.70B | |
| Enterprise Value | $4.53B | $2.65B | $1.49B | · | $2.48B | $3.46B | $2.60B | $1.66B | $648M | $239M | $855M | · | |
| P/E | 9.8 | -9.5 | -3.3 | -4.9 | -5.4 | -9.2 | -11.2 | -10.7 | -5.2 | -3.4 | -10.1 | -17.4 | |
| P/S | 3.6 | 4.3 | 2.2 | · | 5.2 | 11.2 | 9.7 | 6.6 | 3.6 | 4.5 | 29.9 | 67.5 | |
| P/B | -30.1 | -3.2 | -2.5 | · | 1961.8 | 8.8 | 5.0 | 5.0 | 4.4 | 3.1 | 4.9 | 5.7 | |
| P / Cash Flow | 8.7 | -32.6 | -13.2 | · | -11.2 | -21.9 | -30.2 | -62.8 | -69.0 | -3.6 | -8.8 | -29.7 | |
| P / FCF | 8.8 | -30.7 | -11.2 | · | -10.1 | -20.1 | -26.5 | -50.0 | -52.7 | -3.5 | -8.6 | -27.5 | |
| EV / EBITDA | 5.0 | -11.7 | -7.4 | · | -8.0 | -8.9 | -12.5 | -18.6 | -13.9 | -1.8 | -5.1 | · | |
| EV / FCF | 6.5 | -23.2 | -8.0 | · | -8.9 | -16.3 | -23.2 | -47.9 | -49.2 | -2.3 | -6.7 | · | |
| EV / Revenue | 2.6 | 3.3 | 1.6 | · | 4.6 | 9.1 | 8.5 | 6.3 | 3.3 | 2.9 | 23.2 | · | |
| Earnings Yield | 10.2% | -10.5% | -30.4% | -20.4% | -18.6% | -10.9% | -8.9% | -9.3% | -19.2% | -29.4% | -9.9% | -5.7% |
आय विवरण 14
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $361M | $273M | $165M | $211M | $179M | $1.18B | $213M | $197M | $187M | $210M | $307M | $197M | $214M | $220M | $167M | $217M | |
| R&D Expense | $99M | $101M | $133M | $100M | $113M | $109M | $125M | $161M | $132M | $116M | $121M | $164M | $186M | $195M | $189M | $165M | |
| SG&A Expense | $81M | $86M | $97M | $84M | $85M | $81M | $85M | $73M | $70M | $73M | $76M | $81M | $88M | $87M | $93M | $80M | |
| Operating Expenses | $212M | $228M | $236M | $208M | $214M | $206M | $376M | $251M | $227M | $256M | $301M | $315M | $423M | $338M | $368M | $285M | |
| Operating Income | $149M | $45M | $-71M | $3M | $-35M | $970M | $-162M | $-55M | $-40M | $-45M | $6M | $-118M | $-210M | $-118M | $-200M | $-68M | |
| Other Non-op | $-3M | $2M | $-13M | $7M | $-6M | $-6M | $9M | $-2M | $-2M | $2M | $19M | $-20M | $1M | $10M | $35M | $-38M | |
| Pretax Income | $98M | $-2M | $-139M | $-23M | $-71M | $930M | $-95M | $-98M | $-86M | $-85M | $-157M | $-167M | $-237M | $-135M | $-190M | $-127M | |
| Income Tax | $14M | $347.0K | $-4M | $-39M | $-6M | $63M | $-29M | $9M | $13M | $7M | $-1M | $-34M | $-39M | $4M | $-19M | $-18M | |
| Net Income | $83M | $-3M | $-135M | $16M | $-65M | $867M | $-66M | $-107M | $-99M | $-92M | $-156M | $-133M | $-199M | $-139M | $-171M | $-109M | |
| EPS (Basic) | $1.01 | $-0.03 | $-1.88 | $0.20 | $-0.83 | $11.09 | $-0.85 | $-1.39 | $-1.29 | $-1.20 | $-2.07 | $-1.76 | $-2.66 | $-1.88 | $-2.35 | $-1.53 | |
| EPS (Diluted) | $0.92 | $-0.03 | $-1.63 | $0.20 | $-0.83 | $10.04 | $-0.85 | $-1.39 | $-1.29 | $-1.20 | $-2.07 | $-1.76 | $-2.66 | $-1.88 | $-2.35 | $-1.53 | |
| Shares (Basic) | 83,006,808 | 82,521,023 | -155,203,905 | 78,471,119 | 78,151,240 | 78,115,836 | -153,301,665 | 76,925,523 | 76,725,070 | 76,496,127 | -148,999,422 | 75,377,997 | 74,730,433 | 73,729,284 | -142,514,082 | 71,654,671 | |
| Shares (Diluted) | 92,020,009 | 82,521,023 | -163,341,037 | 87,115,369 | 78,151,240 | 86,385,922 | -153,301,665 | 76,925,523 | 76,725,070 | 76,496,127 | -148,999,422 | 75,377,997 | 74,730,433 | 73,729,284 | -142,514,082 | 71,654,671 | |
| EBITDA | $149M | $60M | · | $3M | $-35M | $977M | · | $-55M | $-40M | $10M | · | $-118M | $-210M | $-75M | · | $-68M |
बैलेंस शीट 27
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.05B | $834M | $985M | $673M | $1.02B | $1.48B | $780M | $526M | $655M | $548M | · | $165M | $208M | $167M | · | $104M | |
| Short-term Investments | $1.18B | $1.06B | $961M | $1.02B | $972M | $547M | $360M | $487M | $439M | $336M | · | $130M | $130M | $119M | · | $184M | |
| Receivables | $239M | $220M | $182M | $203M | $196M | $210M | $159M | $200M | $187M | $198M | · | $166M | $178M | $202M | · | $124M | |
| Inventory | $91M | $76M | $80M | $53M | $34M | $22M | $23M | $36M | $32M | $30M | · | $36M | $32M | $27M | · | $15M | |
| Prepaid Expense | $58M | $66M | $67M | $64M | $54M | $57M | $44M | $33M | $46M | $56M | · | $44M | $42M | $99M | · | $90M | |
| Current Assets | $2.62B | $2.25B | $2.27B | $2.01B | $2.27B | $2.32B | $1.37B | $1.28B | $1.36B | $1.17B | · | $540M | $590M | $613M | · | $517M | |
| PP&E (Net) | $51M | $53M | $55M | $57M | $57M | $59M | $61M | $63M | $66M | $93M | · | $85M | $82M | $79M | · | $67M | |
| PP&E (Gross) | · | · | $102M | · | · | · | $94M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $47M | · | · | · | $33M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $82M | $82M | $82M | $82M | $82M | $82M | $82M | $82M | $82M | $82M | · | $82M | $82M | $82M | · | $82M | |
| Intangibles | $403M | $381M | $389M | $396M | $144M | $118M | $119M | $330M | $330M | $330M | · | $423M | $452M | $686M | · | $750M | |
| Total Assets | $3.25B | $2.87B | $2.90B | $2.64B | $2.63B | $2.66B | $1.71B | $1.84B | $1.92B | $1.79B | · | $1.26B | $1.34B | $1.61B | · | $1.58B | |
| Accounts Payable | $40M | $25M | $45M | $37M | $27M | $15M | $17M | $13M | $24M | $27M | · | $19M | $26M | $26M | · | $21M | |
| Current Liabilities | $771M | $924M | $968M | $866M | $628M | $595M | $581M | $611M | $610M | $575M | · | $492M | $476M | $442M | · | $420M | |
| Capital Leases | $88M | $90M | $94M | $95M | $71M | $74M | $75M | $83M | $79M | $105M | · | $100M | $100M | $100M | · | $102M | |
| Deferred Tax | · | · | · | · | · | · | · | $56M | $56M | $56M | · | $52M | $52M | $103M | · | $137M | |
| Other Non-current Liabilities | $15M | $14M | $14M | $3M | $8M | $22M | $21M | $77.0K | $141.0K | $141.0K | · | $141.0K | $141.0K | $141.0K | · | $5M | |
| Total Liabilities | $3.42B | $3.05B | $3.10B | $2.80B | $2.84B | $2.84B | $2.80B | $2.90B | $2.90B | $2.68B | · | $1.93B | $1.92B | $2.07B | · | $1.80B | |
| Long-term Debt | $591M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | $591M | $287M | · | $286M | $286M | $286M | · | $285M | $285M | $285M | · | $573M | $573M | $572M | · | $283M | |
| Common Stock | $82.0K | $81.0K | $80.0K | $79.0K | $78.0K | $78.0K | $77.0K | $76.0K | $76.0K | $76.0K | · | $75.0K | $75.0K | $73.0K | · | $71.0K | |
| Paid-in Capital | $2.71B | $2.78B | $2.75B | $2.67B | $2.63B | $2.61B | $2.57B | $2.53B | $2.51B | $2.49B | · | $2.45B | $2.42B | $2.34B | · | $2.22B | |
| Retained Earnings | $-2.88B | $-2.97B | $-2.96B | $-2.83B | $-2.85B | $-2.78B | $-3.65B | $-3.58B | $-3.47B | $-3.38B | · | $-3.13B | $-2.99B | $-2.80B | · | $-2.49B | |
| AOCI | $6M | $8M | $11M | $6M | $7M | $-14M | $-26M | $-4M | $-16M | $-6M | · | $10M | $-1M | $-2M | · | $36M | |
| Stockholders' Equity | $-165M | $-180M | $-205M | $-156M | $-207M | $-186M | $-1.10B | $-1.05B | $-980M | $-894M | $-819M | $-671M | $-579M | $-458M | $-347M | $-227M | |
| Liabilities + Equity | $3.25B | $2.87B | $2.90B | $2.64B | $2.63B | $2.66B | $1.71B | $1.84B | $1.92B | $1.79B | · | $1.26B | $1.34B | $1.61B | · | $1.58B | |
| Shares Outstanding | 83,327,286 | 82,882,024 | 81,474,366 | 79,931,766 | 79,378,145 | 79,225,276 | 77,704,188 | 76,952,124 | 76,900,123 | 76,653,960 | · | 75,459,022 | 75,318,233 | 74,012,034 | · | 71,854,892 |
नकदी प्रवाह 13
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $16M | $15M | $13M | $11M | $8M | $7M | $7M | $6M | $7M | $55M | $81M | $62M | $51M | $43M | $39M | $34M | |
| Stock-based Comp | $23M | $23M | $19M | $19M | $19M | $18M | $17M | $20M | $19M | $18M | $17M | $27M | $29M | $29M | $27M | $29M | |
| Deferred Tax | · | $-10.0K | $1.0K | · | · | $2.0K | $-56M | $-3.0K | $2.0K | $-1.0K | $4M | $-2.0K | $-51M | $-4.0K | · | · | |
| Amort. of Intangibles | $12M | $12M | $9M | $8M | $4M | $4M | $3M | $3M | $3M | $52M | $77M | $59M | $47M | $39M | $36M | $31M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | · | $23M | $8M | · | · | · | |
| Other Non-cash | · | $-95M | · | · | · | $-22M | · | · | · | $89M | · | · | · | $38M | · | · | |
| Operating Cash Flow | $129M | $-59M | $-34M | $-66M | $-58M | $870M | $-30M | $-77M | $-71M | $71M | $-100M | $-15M | $-14M | $-29M | $-166M | $-38M | |
| CapEx | $2M | $1M | $2M | $3M | $1M | $2M | $4M | $522.0K | $-7M | $10M | $6M | $6M | $6M | $10M | $9M | $5M | |
| Investing Cash Flow | $-123M | $-94M | $34M | $-290M | $-422M | $-184M | $268M | $-43M | $-66M | $-115M | $-94M | $-30M | $-24M | $-29M | $32M | $136M | |
| Financing Cash Flow | $212M | $6M | $303M | $15M | $4M | $9M | $26M | $-18M | $246M | $540.0K | $620M | $3M | $18M | $4M | $303M | $-140M | |
| Net Change in Cash | $216M | $-148M | $312M | $-347M | $-463M | $701M | $256M | $-129M | $104M | $-46M | $429M | $-43M | $-9M | $-62M | $175M | $-54M | |
| Taxes Paid | · | · | $-3M | $936.0K | $36M | $3M | $5M | $7M | $4M | $2M | $524.0K | $4M | $7M | $2M | $893.0K | $1M | |
| Free Cash Flow | · | $-60M | · | · | · | $868M | · | · | · | $61M | · | · | · | $-40M | · | · |
लाभप्रदता 7
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 41.3% | 16.5% | · | 1.4% | -19.5% | 82.5% | · | -27.7% | -21.5% | -21.6% | · | -60.1% | -98.0% | -53.4% | · | -31.4% | |
| Net Margin | 23.2% | -1.0% | · | 7.5% | -36.2% | 73.7% | · | -54.2% | -53.1% | -43.6% | · | -67.6% | -93.0% | -63.0% | · | -50.3% | |
| Pretax Margin | 27.1% | -0.90% | · | -10.9% | -39.7% | 79.1% | · | -49.8% | -45.9% | -40.3% | · | -84.8% | -111.1% | -61.3% | · | -58.6% | |
| EBITDA Margin | 41.3% | 22.1% | · | 1.4% | -19.5% | 83.1% | · | -27.7% | -21.5% | 4.7% | · | -60.1% | -98.0% | -33.9% | · | -31.4% | |
| ROA | 2.8% | -0.10% | · | 0.71% | -2.9% | 39.0% | · | -6.9% | -6.1% | -5.4% | · | -9.4% | -12.7% | -8.2% | · | -6.1% | |
| ROE | -44.9% | 1.5% | · | -2.6% | 10.9% | -160.5% | · | 12.4% | 12.7% | 13.6% | · | 29.6% | 52.2% | 50.7% | · | 179.2% | |
| ROIC | 30.0% | 48.2% | · | -1.6% | -40.2% | 904.6% | · | 7.7% | 6.7% | 8.1% | · | 96.6% | 2648.9% | -105.7% | · | -104.9% |
तरलता और शोधन क्षमता 4
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | 2.4 | · | 2.3 | 3.6 | 3.9 | · | 2.1 | 2.2 | 2.0 | · | 1.1 | 1.2 | 1.4 | · | 1.2 | |
| Quick Ratio | 3.2 | 2.3 | · | 2.2 | 3.5 | 3.8 | · | 2.0 | 2.1 | 1.9 | · | 0.9 | 1.1 | 1.1 | · | 1.0 | |
| Debt / Equity | -3.6 | -1.6 | · | -1.8 | -1.4 | -1.5 | · | -0.3 | -0.3 | -0.3 | · | -0.9 | -1.0 | -1.3 | · | -1.2 | |
| LT Debt / Equity | -3.2 | · | · | · | -1.4 | -1.5 | · | -0.3 | -0.3 | -0.3 | · | -0.9 | -1.0 | -1.3 | · | -1.2 |
दक्षता 2
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.5 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 1.7 | 1.3 | · | 1.0 | 0.9 | 5.8 | · | 1.1 | 1.0 | 1.1 | · | 1.4 | 1.4 | 1.3 | · | 2.0 |
मूल्यांकन (TTM) 13
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.02B | $1.84B | · | $1.76B | $1.74B | $1.77B | · | $790M | $807M | $841M | · | $848M | $817M | $752M | · | $670M | |
| Net Income TTM | $32M | $815M | · | $711M | $596M | $569M | · | $-430M | $-523M | $-562M | · | $-580M | $-599M | $-527M | · | $-522M | |
| Market Cap | $6.80B | $5.65B | · | $4.91B | $3.88B | $4.04B | · | $2.85B | $2.35B | $2.23B | · | $1.69B | $3.06B | $3.59B | · | $3.61B | |
| Enterprise Value | $5.16B | $4.04B | · | $3.50B | $2.17B | $2.30B | · | $2.13B | $1.54B | $1.63B | · | $1.97B | $3.30B | $3.87B | · | $3.60B | |
| P/E | 313.7 | 7.3 | · | 7.7 | 7.5 | 8.3 | · | -6.6 | -4.4 | -3.9 | · | -2.9 | -5.0 | -6.6 | · | -6.8 | |
| P/S | 6.6 | 3.1 | · | 2.8 | 2.2 | 2.3 | · | 3.6 | 2.9 | 2.7 | · | 2.0 | 3.8 | 4.8 | · | 5.4 | |
| P/B | -41.1 | -31.3 | · | -31.5 | -18.8 | -21.7 | · | -2.7 | -2.4 | -2.5 | · | -2.5 | -5.3 | -7.8 | · | -15.9 | |
| P / Cash Flow | · | -95.6 | · | · | · | 4.6 | · | · | · | 31.5 | · | · | · | -121.6 | · | · | |
| P / FCF | · | -93.7 | · | · | · | 4.6 | · | · | · | 36.5 | · | · | · | -90.2 | · | · | |
| EV / EBITDA | 34.6 | 66.9 | · | 1161.8 | -62.2 | 2.3 | · | -39.0 | -38.4 | 163.9 | · | -16.7 | -15.7 | -51.8 | · | -52.8 | |
| EV / FCF | · | -67.1 | · | · | · | 2.6 | · | · | · | 26.6 | · | · | · | -97.4 | · | · | |
| EV / Revenue | 5.0 | 2.2 | · | 2.0 | 1.3 | 1.3 | · | 2.7 | 1.9 | 1.9 | · | 2.3 | 4.0 | 5.1 | · | 5.4 | |
| Earnings Yield | 0.32% | 13.8% | · | 13.1% | 13.4% | 12.1% | · | -15.2% | -22.6% | -25.8% | · | -34.9% | -20.2% | -15.1% | · | -14.6% |
वित्तीय विवरण आय विवरण, बैलेंस शीट, नकदी प्रवाह — वार्षिक, पिछले 5 वर्ष
आय विवरण
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| राजस्व | $1.73B | $807M | $938M | $699M | $539M |
| परिचालन मार्जिन % | 50.1% | -37.5% | -46.9% | — | -69.5% |
| शुद्ध आय | $683M | $-363M | $-627M | $-559M | $-524M |
| तनुकरणित EPS | $7.78 | $-4.73 | $-8.37 | $-7.79 | $-7.43 |
बैलेंस शीट
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| ऋण / इक्विटी | -1.4 | -0.3 | -0.3 | — | 300.0 |
| वर्तमान अनुपात | 2.3 | 2.4 | 2.0 | — | 1.9 |
| त्वरित अनुपात | 2.2 | 2.2 | 1.7 | — | 1.7 |
नकदी प्रवाह
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| फ्री कैश फ्लो | $702M | $-114M | $-187M | — | $-280M |
ट्रेडिंग सिग्नल प्रवेश मूल्य और जोखिम/इनाम अनुपात के साथ हालिया खरीद/बिक्री संकेत
मेरे मेट्रिक्स आपकी व्यक्तिगत वॉचलिस्ट — पूर्ण फंडामेंटल से चयनित पंक्तियाँ
उन मेट्रिक्स को चुनें जो आपके लिए मायने रखते हैं — ऊपर पूर्ण फंडामेंटल में किसी भी पंक्ति के बगल में ➕ पर क्लिक करें।
आपका चयन सहेजा गया है और यह सभी टिकर में आपके साथ रहता है।
संस्थागत मालिक (13F) 405 फाइलर्स · $5.4B कुल · तिथि अनुसार 30 जून 2026
संस्थान जो अपनी तिमाही SEC फॉर्म 13F में इस स्टॉक को होल्ड करने की रिपोर्ट करते हैं। केवल लॉन्ग पोजीशन; एक ही फाइलर अलग-अलग ऑप्शन लेग्स के लिए दो बार दिखाई दे सकता है। बड़े ऑफसेटिंग पुट/कॉल लेग्स आमतौर पर मार्केट-मेकिंग या हेज्ड इन्वेंट्री को दर्शाते हैं, न कि दिशात्मक विश्वास को।
| नई स्थितियाँ | बाहर निकली पोजीशन | बढ़ाया | घटा हुआ | शुद्ध शेयर परिवर्तन |
|---|---|---|---|---|
| 84 (+17 पिछली तिमाही की तुलना में) | 43 (-7 पिछली तिमाही की तुलना में) | 133 (-6 पिछली तिमाही की तुलना में) | 109 (+6 पिछली तिमाही की तुलना में) | -7.1M |
Q1 2026 की तुलना में। SEC फॉर्म 13F फाइलिंग तिमाही के अंत के 45 दिनों के भीतर देय होती है, साथ ही देर से फाइल करने वालों के लिए एक छोटा बफर भी होता है — उस विंडो के भीतर आने वाली तिमाहियों को सबसे हालिया पूरी तरह से रिपोर्ट की गई जोड़ी के पक्ष में छोड़ दिया जाता है।
| संस्था | मूल्य | शेयर | % ट्रैक किए गए 13F का | प्रकार |
|---|---|---|---|---|
| RTW INVESTMENTS, LP | $631875072 | 7746415 | 11.70% | शेयर |
| JANUS HENDERSON GROUP PLC | $479178655 | 7034622 | 8.87% | शेयर |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $401986014 | 4928111 | 7.44% | शेयर |
| STATE STREET CORP | $375136515 | 4598952 | 6.95% | शेयर |
| VANGUARD CAPITAL MANAGEMENT LLC | $305000589 | 3739127 | 5.65% | शेयर |
| WELLINGTON MANAGEMENT GROUP LLP | $292435873 | 3585091 | 5.42% | शेयर |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $159563645 | 1956156 | 2.95% | शेयर |
| GEODE CAPITAL MANAGEMENT, LLC | $155132041 | 1901417 | 2.87% | शेयर |
| Hood River Capital Management LLC | $141818662 | 1738613 | 2.63% | शेयर |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $140519660 | 1722688 | 2.60% | शेयर |
| TANG CAPITAL MANAGEMENT LLC | $122355000 | 1500000 | 2.27% | शेयर |
| Driehaus Capital Management LLC | $117469528 | 1440107 | 2.18% | शेयर |
| Jefferies Financial Group Inc. | $110693916 | 1357042 | 2.05% | शेयर |
| FULLER & THALER ASSET MANAGEMENT, INC. | $94361749 | 1156819 | 1.75% | शेयर |
| Pictet Asset Management Holding SA | $93629635 | 1147844 | 1.73% | शेयर |
| ARMISTICE CAPITAL, LLC | $87393690 | 1071395 | 1.62% | शेयर |
| Blue Sparrow, LLC /DE | $85705599 | 1050700 | 1.59% | शेयर |
| D. E. Shaw & Co., Inc. | $77478857 | 949845 | 1.43% | शेयर |
| Palo Alto Investors LP | $74950268 | 918846 | 1.39% | शेयर |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $64449436 | 790112 | 1.19% | शेयर |
| RENAISSANCE TECHNOLOGIES LLC | $59015895 | 723500 | 1.09% | शेयर |
| Boston Partners | $57080953 | 699871 | 1.06% | शेयर |
| FMR LLC | $56956987 | 698259 | 1.05% | शेयर |
| BANK OF AMERICA CORP /DE/ | $56350840 | 690828 | 1.04% | शेयर |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $53377940 | 654382 | 0.99% | शेयर |
| DIMENSIONAL FUND ADVISORS LP | $51486821 | 631199 | 0.95% | शेयर |
| VANGUARD FIDUCIARY TRUST CO | $47953943 | 587887 | 0.89% | शेयर |
| Ensign Peak Advisors, Inc | $41442128 | 508056 | 0.77% | शेयर |
| AMERICAN CENTURY COMPANIES INC | $40866277 | 500995 | 0.76% | शेयर |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $36050432 | 441957 | 0.67% | शेयर |
| Parkman Healthcare Partners LLC | $35539315 | 435691 | 0.66% | शेयर |
| LOOMIS SAYLES & CO L P | $35387921 | 433835 | 0.66% | शेयर |
| Defilade Capital Management, L.P. | $35376827 | 433699 | 0.66% | शेयर |
| GOLDMAN SACHS GROUP INC | $34153522 | 418702 | 0.63% | शेयर |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $32274149 | 395662 | 0.60% | शेयर |
| BNP PARIBAS FINANCIAL MARKETS | $30892190 | 378720 | 0.57% | शेयर |
| Qube Research & Technologies Ltd | $25398777 | 311374 | 0.47% | शेयर |
| ARMISTICE CAPITAL, LLC | $24471000 | 300000 | 0.45% | कॉल ऑप्शन |
| Public Sector Pension Investment Board | $23249326 | 285023 | 0.43% | शेयर |
| SEGALL BRYANT & HAMILL, LLC | $22165424 | 271735 | 0.41% | शेयर |
| CITADEL ADVISORS LLC | $20338011 | 249332 | 0.38% | शेयर |
| MORGAN STANLEY | $18990210 | 232808 | 0.35% | शेयर |
| Boxer Capital Management, LLC | $16314000 | 200000 | 0.30% | शेयर |
| RHUMBLINE ADVISERS | $15718994 | 192706 | 0.29% | शेयर |
| AMERIPRISE FINANCIAL INC | $13904178 | 170457 | 0.26% | शेयर |
| PRUDENTIAL FINANCIAL INC | $13746176 | 168520 | 0.25% | शेयर |
| BlackRock, Inc. | $13589562 | 166600 | 0.25% | शेयर |
| Rock Springs Capital Management LP | $13238648 | 162298 | 0.25% | शेयर |
| Hudson Bay Capital Management LP | $13033091 | 159778 | 0.24% | शेयर |
| Russell Investments Group, Ltd. | $12687724 | 155544 | 0.23% | शेयर |
| Schonfeld Strategic Advisors LLC | $12025457 | 147425 | 0.22% | शेयर |
| MARSHALL WACE, LLP | $11724301 | 143733 | 0.22% | शेयर |
| Swiss National Bank | $11539300 | 141465 | 0.21% | शेयर |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $11063583 | 135633 | 0.20% | शेयर |
| Legal & General Group Plc | $10362979 | 127044 | 0.19% | शेयर |
| CITIGROUP INC | $9272143 | 113671 | 0.17% | शेयर |
| FIRST TRUST ADVISORS LP | $9246285 | 113354 | 0.17% | शेयर |
| Longaeva Partners L.P. | $9119771 | 111803 | 0.17% | शेयर |
| JUPITER ASSET MANAGEMENT LTD | $8927184 | 109442 | 0.17% | शेयर |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $8215404 | 100716 | 0.15% | शेयर |
| SECTOR GAMMA AS | $8157000 | 100000 | 0.15% | शेयर |
| WCM INVESTMENT MANAGEMENT, LLC | $7651184 | 93799 | 0.14% | शेयर |
| PANAGORA ASSET MANAGEMENT INC | $7256141 | 88956 | 0.13% | शेयर |
| VOYA INVESTMENT MANAGEMENT LLC | $7239501 | 88752 | 0.13% | शेयर |
| ALLIANCEBERNSTEIN L.P. | $7217488 | 105937 | 0.13% | शेयर |
| Aquatic Capital Management LLC | $6808648 | 83470 | 0.13% | शेयर |
| XTX Topco Ltd | $6682459 | 81923 | 0.12% | शेयर |
| MOORE CAPITAL MANAGEMENT, LP | $6165713 | 75588 | 0.11% | शेयर |
| PINNACLE ASSOCIATES LTD | $5745383 | 70435 | 0.11% | शेयर |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $5744722 | 84320 | 0.11% | शेयर |
| VANGUARD ASSET MANAGEMENT, Ltd | $5614300 | 68828 | 0.10% | शेयर |
| Capricorn Fund Managers Ltd | $5212323 | 63900 | 0.10% | शेयर |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5000241 | 61300 | 0.09% | कॉल ऑप्शन |
| INTECH INVESTMENT MANAGEMENT LLC | $4696882 | 57581 | 0.09% | शेयर |
| ExodusPoint Capital Management, LP | $4672166 | 57278 | 0.09% | शेयर |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $4561884 | 55926 | 0.08% | शेयर |
| BARCLAYS PLC | $4169858 | 51120 | 0.08% | शेयर |
| ORBIMED ADVISORS LLC | $4005087 | 49100 | 0.07% | शेयर |
| MetLife Investment Management, LLC | $3932653 | 48212 | 0.07% | शेयर |
| Point72 Europe (London) LLP | $3829919 | 62407 | 0.07% | शेयर |
| MILLENNIUM MANAGEMENT LLC | $3792516 | 46494 | 0.07% | शेयर |
| Phocas Financial Corp. | $3766087 | 46170 | 0.07% | शेयर |
| MARTINGALE ASSET MANAGEMENT L P | $3627826 | 44475 | 0.07% | शेयर |
| Quadrature Capital Ltd | $3589488 | 44005 | 0.07% | शेयर |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3531981 | 43300 | 0.07% | पुट ऑप्शन |
| STATE OF WISCONSIN INVESTMENT BOARD | $3436299 | 42127 | 0.06% | शेयर |
| CREDIT AGRICOLE S A | $3344370 | 41000 | 0.06% | शेयर |
| Fisher Asset Management, LLC | $3322345 | 40730 | 0.06% | शेयर |
| HSBC HOLDINGS PLC | $3200425 | 38732 | 0.06% | शेयर |
| NEW YORK STATE COMMON RETIREMENT FUND | $3134490 | 38427 | 0.06% | शेयर |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $3114179 | 38178 | 0.06% | शेयर |
| CenterBook Partners LP | $3082938 | 37795 | 0.06% | शेयर |
| Rafferty Asset Management, LLC | $3069805 | 37634 | 0.06% | शेयर |
| FIFTH THIRD BANCORP | $3044843 | 37328 | 0.06% | शेयर |
| BURNEY CO/ | $3044192 | 37320 | 0.06% | शेयर |
| Vanguard Global Advisers, LLC | $3033180 | 37185 | 0.06% | शेयर |
| Arrowpoint Investment Partners (Singapore) Pte. Ltd. | $3007731 | 36873 | 0.06% | शेयर |
| Louisiana State Employees Retirement System | $2969148 | 36400 | 0.05% | शेयर |
| JANE STREET GROUP, LLC | $2854950 | 35000 | 0.05% | पुट ऑप्शन |
| CASTLEARK MANAGEMENT LLC | $2765223 | 33900 | 0.05% | शेयर |
कंपनी के अंदरूनी सूत्र 33 इनसाइडर्स · 13 अधिकारी · 14 निदेशक
| अंदरूनी | भूमिका | अंतिम गतिविधि | शेयरों का स्वामित्व | खरीद 12m | बिक्री 12m | नेट 12m |
|---|---|---|---|---|---|---|
| Stuart Walter Peltz | Chief Executive Officer | 1 फ़रवरी 2022 S | 38728 | 0 | 0 | $0 |
| Pierre Gravier | CHIEF FINANCIAL OFFICER | 14 जुलाई 2026 S | 83986 | 0 | 1 | $-280743 |
| Emily Luisa Hill | Chief Financial Officer | 1 फ़रवरी 2022 S | 37169 | 0 | 0 | $0 |
| Shane William Charles Kovacs | Chief Financial Officer | 9 मई 2017 M | 37850 | 0 | 0 | $0 |
| Claudia De Oliveira Ribeiro Hirawat | President | 15 जनवरी 2015 M | 39247 | 0 | 0 | $0 |
| Marcio Souza | Chief Operating Officer | 10 फ़रवरी 2020 M | 6744 | 0 | 0 | $0 |
| Neil Gregory Almstead | CHIEF TECHNICAL OPS OFFICER | 9 जुलाई 2026 M | 60299 | 0 | 20 | $-9184852 |
| Mark Elliott Boulding | EXEC. VP AND CLO | 6 जुलाई 2026 M | 105272 | 0 | 12 | $-1254986 |
| Christine Marie Utter | SVP, CHIEF ACCOUNTING OFFICER | 17 जून 2026 M | 70199 | 0 | 1 | $-1487474 |
| Eric Pauwels | CHIEF BUSINESS OFFICER | 10 जून 2026 S | 73411 | 0 | 28 | $-7477160 |
| Mark Rothera | Chief Commercial Officer | 24 मई 2017 M | 33739 | 0 | 0 | $0 |
| Tuyen Ong | Chief Medical Officer | 3 जनवरी 2017 A | 6000 | 0 | 0 | $0 |
| Robert J. Spiegel | Chief Medical Officer | 4 जनवरी 2016 A | 3239 | 0 | 0 | $0 |
| Hege Elisabeth Sollie-Zetlmayer | निदेशक | 28 जुलाई 2026 A | 52526 | 0 | 0 | $0 |
| Mary L. Smith | निदेशक | 9 जुलाई 2026 M | 21813 | 0 | 2 | $-1425060 |
| Stephanie Okey | निदेशक | 7 जनवरी 2022 A | 4163 | 0 | 0 | $0 |
| Emma Reeve | निदेशक | 7 जनवरी 2022 A | 7528 | 0 | 0 | $0 |
| Allan Steven Jacobson | निदेशक | 7 जनवरी 2022 A | 8348 | 0 | 0 | $0 |
| Dawn Svoronos | निदेशक | 7 जनवरी 2022 A | 29755 | 0 | 0 | $0 |
| Jerome B Zeldis | निदेशक | 7 जनवरी 2022 A | 6500 | 0 | 0 | $0 |
| Cameron Geoffrey Mcdonough | निदेशक | 3 जनवरी 2017 A | — | 0 | 0 | $0 |
| Adam Koppel | निदेशक | 3 जनवरी 2017 A | 2333333 | 0 | 0 | $0 |
| Ronald C Renaud JR | निदेशक | 3 जनवरी 2017 A | — | 0 | 0 | $0 |
| Richard Aldrich | निदेशक | 8 जून 2015 M | 0 | 0 | 0 | $0 |
| Michael L Kranda | निदेशक | 16 मार्च 2015 S | 2242 | 0 | 0 | $0 |
| Axel Bolte | निदेशक | 25 जून 2013 P | 20000 | 0 | 0 | $0 |
| HBM Healthcare Investments (Cayman) Ltd. | 10% मालिक | 17 दिसमबर 2013 S | 2441504 | 0 | 0 | $0 |
| Matthew B. Klein | — | 4 अगस्त 2026 S | 383868 | 0 | 1 | $-705722 |
| Michael Schmertzler | — | 2 जनवरी 2026 A | 163266 | 0 | 0 | $0 |
| Glenn Steele JR MD PHD | — | 2 जनवरी 2026 A | 22500 | 0 | 1 | $-916200 |
| David P Southwell | — | 2 जनवरी 2026 A | 20850 | 0 | 0 | $0 |
| Complete Pharma Holdings II, LLC | — | 28 अप्रैल 2017 J | 0 | 0 | 0 | $0 |
| CREDIT SUISSE/ | — | 25 जून 2013 C | 2256882 | 0 | 0 | $0 |
SEC फॉर्म 3/4/5 फाइलिंग से अंदरूनी सूत्र; नेट = केवल ओपन-मार्केट P/S
कार्यकर्ता और 5%+ मालिक 3 होल्डिंग्स
जिन निवेशकों ने SEC शेड्यूल 13D दाखिल किया है — जारीकर्ता को प्रभावित करने के इरादे से 5% से अधिक लाभकारी स्वामित्व (कार्यकर्ता दांव, बोर्ड अभियान, M&A)। प्रत्येक पंक्ति उस फाइलर की स्थिति की सबसे हालिया ज्ञात स्थिति दिखाती है।
| फाइलर | दाखिल किया | दांव | स्थिति | उद्देश्य | फाइलिंग |
|---|---|---|---|---|---|
| Brookside Capital Partners Fund, L.P., Brookside Capital Trading Fund, L.P. ×5 फाइलिंग | 30 जनवरी 2015 | — | प्रारंभिक फाइलिंग | — | SEC |
| HBM Healthcare Investments (Cayman) Ltd. (“HBM”) ×2 फाइलिंग | 12 नवमबर 2014 | — | प्रारंभिक फाइलिंग | — | SEC |
| HBM Healthcare Investments (Cayman) Ltd. | 5 जुलाई 2013 | — | प्रारंभिक फाइलिंग | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ईटीएफ स्वामित्व 88 ETFs द्वारा धारित
वजन केवल प्रत्यक्ष इक्विटी होल्डिंग्स (N-PORT) को दर्शाता है; लीवरेज्ड या डेरिवेटिव-आधारित फंड में अतिरिक्त स्वैप एक्सपोजर हो सकता है जो नहीं दिखाया गया है।
| फंड | भार | इकाइयाँ | तिथि अनुसार | स्रोत |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1.37% | 12510 NS | 30 अप्रैल 2026 | N-PORT |
| SIXS · EXCHANGE TRADED CONCEPTS TRUST | 1.30% | 22380 NS | 31 मई 2026 | N-PORT |
| GURU · Global X Funds | 1.03% | 9268 NS | 30 अप्रैल 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.93% | 73928 NS | 30 अप्रैल 2026 | N-PORT |
| VAMO · Cambria ETF Trust | 0.83% | 10625 NS | 30 अप्रैल 2026 | N-PORT |
| VMAX · Lattice Strategies Trust | 0.72% | 5120 NS | 30 अप्रैल 2026 | N-PORT |
| FNY · First Trust Exchange-Traded AlphaDE… | 0.51% | 40257 NS | 30 अप्रैल 2026 | N-PORT |
| MMSC · First Trust Exchange-Traded Fund VI… | 0.49% | 3490 NS | 31 मई 2026 | N-PORT |
| CLSE · Trust for Professional Managers | 0.49% | 40488 NS | 31 मई 2026 | N-PORT |
| PSC · Principal Exchange-Traded Funds | 0.47% | 135289 NS | 30 जून 2026 | N-PORT |
| HQGO · Lattice Strategies Trust | 0.43% | 3203 NS | 30 अप्रैल 2026 | N-PORT |
| OASC · Unified Series Trust | 0.40% | 4569 NS | 31 मई 2026 | N-PORT |
| BRNY · EA Series Trust | 0.40% | 34057 NS | 30 अप्रैल 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.34% | 35034 NS | 31 मई 2026 | N-PORT |
| ESSC · Strategy Shares | 0.34% | 1335 NS | 30 अप्रैल 2026 | N-PORT |
| BIB · ProShares Trust | 0.31% | 3062 NS | 31 मई 2026 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0.31% | 11451 NS | 31 मई 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0.30% | 39411 NS | 31 मई 2026 | N-PORT |
| SAA · ProShares Trust | 0.26% | 961 NS | 31 मई 2026 | N-PORT |
| ROUS · Lattice Strategies Trust | 0.25% | 22443 NS | 30 अप्रैल 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0.24% | 27276 NS | 30 अप्रैल 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0.23% | 2877 NS | 30 अप्रैल 2026 | N-PORT |
| AFSM · First Trust Exchange-Traded Fund VI… | 0.23% | 3003 NS | 31 मई 2026 | N-PORT |
| FNX · First Trust Exchange-Traded AlphaDE… | 0.20% | 39967 NS | 30 अप्रैल 2026 | N-PORT |
| RSSL · Global X Funds | 0.16% | 34125 NS | 30 अप्रैल 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.15% | 11071 NS | 30 अप्रैल 2026 | N-PORT |
| ITWO · ProShares Trust | 0.15% | 3710 NS | 31 मई 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0.14% | 49932 NS | 30 अप्रैल 2026 | N-PORT |
| SMDX · Tidal Trust III | 0.13% | 2579 NS | 30 अप्रैल 2026 | N-PORT |
| SXQG · EXCHANGE TRADED CONCEPTS TRUST | 0.13% | 1182 NS | 31 मई 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.13% | 386068 NS | 31 मई 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.09% | 190421 NS | 30 अप्रैल 2026 | N-PORT |
| UWM · ProShares Trust | 0.09% | 2899 NS | 31 मई 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.08% | 33415 NS | 30 अप्रैल 2026 | N-PORT |
| FYEE · Fidelity Greenwood Street Trust | 0.07% | 1913 NS | 30 अप्रैल 2026 | N-PORT |
| URTY · ProShares Trust | 0.06% | 2936 NS | 31 मई 2026 | N-PORT |
| FBUF · Fidelity Greenwood Street Trust | 0.05% | 154 NS | 30 अप्रैल 2026 | N-PORT |
| AFMC · First Trust Exchange-Traded Fund VI… | 0.05% | 1112 NS | 31 मई 2026 | N-PORT |
| TILT · FlexShares Trust | 0.04% | 13552 NS | 30 अप्रैल 2026 | N-PORT |
| HDG · ProShares Trust | 0.03% | 74 NS | 31 मई 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.02% | 6829 NS | 30 अप्रैल 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.01% | 95919 NS | 30 अप्रैल 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0.01% | 17796 NS | 31 मई 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0.01% | 47658 NS | 31 मई 2026 | N-PORT |
| AVSU · AMERICAN CENTURY ETF TRUST | 0.01% | 506 NS | 31 मई 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0.01% | 273 NS | 31 मई 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.01% | 21258 NS | 30 अप्रैल 2026 | N-PORT |
| FHEQ · Fidelity Greenwood Street Trust | 0.01% | 861 NS | 30 अप्रैल 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 7872 NS | 30 अप्रैल 2026 | N-PORT |
| FTLS · First Trust Exchange-Traded Fund III | -0.10% | -33590 NS | 30 अप्रैल 2026 | N-PORT |